| abstract |
The invention discloses benzamido carboxylic acid compound new shown in compound of formula I, its optical isomer and racemic modification, with its physiologically acceptable salt, solvate and crystal form, the preparation method of described compound, containing the pharmaceutical preparation of described compound, and the application that described compound is in the clinic that treatment is relevant with insulin resistance. |